Sign in

CIK 0000943819 · Large accelerated filer

RESMED INC

Sign in to watch
Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
980152841
Phone
8587462400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,744,605
in 5 filings, $3.7M under 10b5-1 plans

Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Farrell Michael J. −$3.4M Chairman and CEO sold 3% of stake
  2. FARRELL PETER C −$228K Director sold 2% of stake
  3. Rider Michael J −$102K Global General Counsel sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-15 Douglas Robert Andrew President and COO Option exercise +16,888 $58.24 $984K 39,597
2022-09-15 Douglas Robert Andrew President and COO Sale −11,189 $232.51 $2.6M 28,408
2022-09-15 Douglas Robert Andrew President and COO Sale −6,000 $232.38 $1.4M 228,995
2022-09-15 Douglas Robert Andrew President and COO Gift −1,287 227,708
2022-09-15 Douglas Robert Andrew President and COO Option exercise · ResMed Common Stock Options −1,145 52,953
2022-09-15 Douglas Robert Andrew President and COO Option exercise · ResMed Common Stock Options −16,888 36,065
2022-09-06 PENDARVIS DAVID Chief Administrative Officer Sale −1,545 $216.92 $335K 105,424
2022-08-18 Ghoshal Kaushik President, SaaS Business Grant or award +3,366 14,628
2022-08-18 PENDARVIS DAVID Chief Administrative Officer Grant or award +1,683 106,969
2022-08-18 Sandercock Brett Chief Financial Officer Grant or award +3,847 110,273
2022-08-18 Douglas Robert Andrew President and COO Grant or award +4,328 21,564
2022-08-18 Farrell Michael J. Chief Executive Officer Grant or award +17,310 422,570
2022-08-15 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 410,935
2022-08-15 Farrell Michael J. Chief Executive Officer Sale −5,675 $238.09 $1.4M 405,260
2022-08-15 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 88,590
2022-08-10 Sandercock Brett Chief Financial Officer Option exercise +2,500 $57.76 $144K 108,926
2022-08-10 Sandercock Brett Chief Financial Officer Sale −2,500 $240.66 $602K 106,426
2022-08-10 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options −2,500 0
2022-08-03 PENDARVIS DAVID Chief Administrative Officer Sale −1,545 $240.72 $372K 105,286
2022-07-22 Sandercock Brett Chief Financial Officer Option exercise +2,500 $57.76 $144K 108,926

Page 26 of 28 · 548 trades